Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The major factor propelling the market demand are rising applications of collagen in medical industry. The collagen has increasing become a successful and widely used medical product. And has specifically gain widespread clinical and consumer acceptance for being seen as a safe material with the properties that can adapt to meet the range of different clinical applications. Besides, collagen products are mostly used in medicine and dentistry for many purposes including wound dressing and as a matrices for the tissue growth. As it is the chief structural protein of the body. Furthermore, growing FDA approvals and product launches and increasing research activities for collagen based medical products has certainly boosted the demand for the market worldwide. This factor is expected to create of growth opportunity for market over the forecast period.
The market is expected to witness increasing opportunities in the global medical collagen market attributing to growing consumer consciousness for healthy skin coupled with the shifting inclination towards the use of supplement and neutraceuticals which is expected to create rising new growth opportunity for the market demand. Besides, constant investment in research and development activities for healthy skin coupled with the inclination towards use of the medical collagen is expected to create ample of new growth opportunities for the market.
The major restraining factor for the global medical collagen market is higher price of the collagen. The price of collagen mostly differ from product to product and based on the source. Besides, constant emerging different brands products but with higher price is expected to restrain the market growth to major extend.
The report provides in-depth analysis of global medical collagen market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. With increasing demand for various medical collagen in various applications has led the increasing demand for market and is expected to witness the growth at a specific CAGR of 6.10% from 2022-2028.
The global medical collagen market comprises of different market segment like source, product, application and geography.
The source is studied in the global medical collagen market are bovine, porcine. The bovine collagen is expected to gain major market share during the forecast period. Bovine collagen is a common supplement or food additive derived from the cows and offers number of health benefits such as improved skin health and bone loss prevention. Bovine collagen ideally helps to strengthen various body structure and integrity of the skin and is widely used in different clinical applications. On the other hand, porcine is likely to contribute healthy growth for the market as porcine collagen is derived from pig’s bone and skin. Besides, the gelatin is mostly rich in porcine collagen peptides and is more bioavailable than native pork collagen.
The medical collagen market by product includes various segment like gelatine, hydrolysed collagen, and native collagen. Gelatin is the leading segment in market during the estimated time period. Gelatin is a protein product derived from the collagen. And ideally have important health benefits due to its unique combination of amino acids. Gelatin has been shown to play a specific role in joint health and brain function and may improve the appearance of skin and hair. Furthermore, gelatin is made of 98-99% of protein and remaining 1-2% is water and small amounts of vitamin and minerals. Furthermore, gelatin is also known as richest food source of the amino acid glycine.
The global medical collagen market finds its major application in wound care, bone grafts, tissue scaffolds, cartilage repair, haemostats, diagnostics, and vascular grafts. Wound care is expected to dominate in the medical collagen market and maintain its dominance over the estimated time period. With the continued increase in aging population, and associated comorbidities, preventative strategies and accurate wound assessment has specifically fuel the requirement for the wound care which has ultimately created emerging demand for medical collagen market. Collagen wound dressing mostly stimulate the growth of new tissue in wound by promoting the deposition and organization of new collagen fibers in it. Adding to that, tissue scaffolds mostly have increasing demand for medical collagen to in vivo – to support the regrowth of tissue or bone after surgery or an injury. The market product specifically helps to strength and structure.
The global medical collagen market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is likely to witness increasing demand for medical collagen market. The major factor propelling the market growth are increasing geriatric population, increasing awareness for use of medical collagen for skin, muscles and bones has specifically contributed in the market. Besides, rising applications of collagen in medical industry, growing FDA approvals and product launches and increasing research activities for collagen based medical products is expected to provide ample of growth opportunities for the market over the estimated time period. Besides, presence of well-established manufacturer operating in medical collagen market is propelling the market growth. Alternatively, Asia Pacific is expected to have rising demand for medical collagen market attributing presence of economies countries like China, India, among others. The increasing population, trauma, injuries has specifically accelerated the requirement for medical collagen market.
The competitive landscape analysis of medical collagen market is certainly based range of market players operating in the healthcare market with increasing demand for production of medical collagen. Besides, number of market players offered wide range of products for different application in various geographic locations. The market has major competitive analysis based on new product launches as well as other developments.
December 2021: Mallinckrodt plc had announced the enrollment of the first patient in StrataSOMA, a phase ½ a clinical trial that is assessing StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen for investigational treatment of adults with third degree full thickness thermal burns.
November 2020: Maypharm Co. Ltd had announce the launch of a new PLA meNnus (200mg/vial) which is available at Maypharm. MENNUS is a new combination of mesotherapy and biotechnology directed to fill shelves of professional cosmetics. Main power of effect is coming from ingredients: Poly-D, L-lactic Acid (PLA) maintained with Carboxymethyl Cellulose (CMC) in co-operation, both give the longest collegen regeneration that lasts up to 18-24 months. CMC gels immediately fills dermis with insufficient volume, providing PLA new cells to create more collagen than before.
November 2018: BioCell Technology, LLC had announced the flagship of clinically tested healthy aging ingredient. The company had launched the stand alone ingredient featured in a new dietary supplement from the esteemed finished product manufacturing NOW. NOW’s BioCell Collagen deliver 1,000 mg in two capsules providing > 570 mg of type II collagen peptides, >95 mg of hyaluronic acid and >190 mg of chondroitin sulfate. The ingredient supports the joint, skin and connective tissue health.
Medical collagen is a protein made up of amino acids, which are in turn built of carbon, oxygen and hydrogen. Collagen contain specific amino acids like glycine, proline, hydroxyproline and arginine. Adding to that collagen in medical industry is one of the most powerful protein that works as a flexible glue of sorts and can hold and binds the cells in the connective tissue together. Furthermore, medical collagen is mostly used to treat wounds including burns, cuts, chronic wounds that heal slow or refuse to heal at all, bed sores, ulcer of various kinds specifically has rising demand for market products. With the changing population dynamics, increasing number of injuries, demand for various medical collagen in different applications due to their advantages and benefits has led the emerging new growth opportunity for the market.
The global medical collagen market comprises of different market segment like source, product, application and geography. The source is studied in the global medical collagen market are bovine, porcine. The bovine collagen is expected to gain major market share during the forecast period. The medical collagen market by product includes various segment like gelatine, hydrolysed collagen, and native collagen. Gelatin is the leading segment in market during the estimated time period. The global medical collagen market finds its major application in wound care, bone grafts, tissue scaffolds, cartilage repair, haemostats, diagnostics, and vascular grafts. Wound care is expected to dominate in the medical collagen market and maintain its dominance over the estimated time period. The global medical collagen market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW).
1) What are the drivers for medical collagen market?
The key driving factors of the market are rising applications of collagen in medical industry, growing FDA approvals and product launches, increasing research activities for collagen based medical products
2) Which product is expected to dominate in the market?
Gelatine is likely to have increasing demand in the market over the estimated time period.
3) Which is the leading application segment for medical collagen market?
Wound care has accounted the major market share, and is expected to witness the growth at highest pace during the forecast period.
4) Which region is gaining majority of market share during the forecast period (2021-2028)?
North America is expected to gain major market share during the forecast period (2021-2028).
